DALLAS, April 4, 2013 /PRNewswire/ --
The North America Injectable Drug Delivery Market- by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] - Forecasts to 2017 analyzes and studies the major market drivers, restraints, and opportunities in United States and Canada.
Early buyers will receive 10% customization on this report.
This report studies the North American injectable drug delivery technologies market over the forecast period of 2012-2017.
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012 and is poised to grow at a CAGR of 12.3% from 2012 to 2017 to reach $16.6 billion by 2017.
The injectable drug delivery technologies market is broadly categorized into two major segments, namely, devices technologies and formulation technologies. Based on product, the injectable drug delivery devices technologies market is further categorized into conventional injection devices, self injection devices, and others (microneedles, nanoneedles and blunt needle injections), while injectable drug delivery formulation technologies market is categorized into conventional drug delivery formulations and novel drug delivery formulations. Conventional injection
Copyright©2012 PR Newswire.
All rights reserved